Evidence map›Paper›PMID 28463573›Full record

ReviewBioengineered2018

Bioengineering toward direct production of immobilized enzymes: A paradigm shift in biocatalyst design.

Fabian B H Rehm, Shuxiong Chen, Bernd H A Rehm

Abstract readReview
In one paragraph

Review in Bioengineered, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Magnetically Recoverable ICT-Functionalized FeMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fabian B H Rehma Institute for Molecular Bioscience, The University of Queensland , St Lucia , Brisbane , Australia.
Shuxiong Chenb Institute of Fundamental Sciences, Massey University , Palmerston North , New Zealand.
Bernd H A Rehmb Institute of Fundamental Sciences, Massey University , Palmerston North , New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for cost-effectively produced and improved biocatalysts for industrial, pharmaceutical and environmental processes is steadily increasing. While enzyme properties themselves can be improved via protein engineering, immobilization by attachment to carrier materials remains a critical step for stabilization and process implementation. A new emerging immobilization approach, the in situ immobilization, enables simultaneous production of highly active enzymes and carrier materials using bioengineering/synthetic biology of microbial cells. In situ enzyme immobilization holds the promise of cost-effective production of highly functional immobilized biocatalysts for uses such as in bioremediation, drug synthesis, bioenergy and food processing.

Indexed as

AdsorptionBiocatalysisBiodegradation, EnvironmentalCross-Linking ReagentsEnzymes, ImmobilizedFood HandlingGene ExpressionInclusion BodiesMagnetosomesPolyhydroxyalkanoatesProtein EngineeringProteolipidsRecombinant Fusion ProteinsCross-Linking ReagentsEnzymes, ImmobilizedPolyhydroxyalkanoatesProteolipidsproteoliposomesRecombinant Fusion Proteinsbiocatalystbiopolymerenzymeimmobilizationpolyhydroxyalkanoateself-assembly

Identifiers

PMID28463573
PMCPMC5972917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.